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Unusual Rapid Evolution of Type B Aortic Dissection in
a Marfan Patient Following Heart Transplantation:
Successful Endovascular Treatment
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A patient with Marfan syndrome with previous Bentall operation for mitral and tricuspid valve repair, required orthotopic
cardiac transplantation for end stage cardiomyopathy. Postoperatively he suffered type-B aortic dissection, despite normal
aortic diameters. Following sudden increase of aortic diameters, two years later, he underwent successful stent graft im-
plantation. In patients with Marfan syndrome, post transplantation morbidity is high, with a 40% incidence of thoracic
aortic dissection. This case highlights the potential of endovascular approach for treating post-transplantation aortic
dissection.
Keywords: Marfan syndrome; Heart transplantation; Type-B aortic dissection; Endovascular stent-graft.Introduction
Marfan syndrome is an autosomal dominant disorder
of connective tissue, characterised by highly variable
clinical manifestations primarily in skeletal, ocular
and cardiovascular organ systems.1 Usually the car-
diovascular manifestations, such as progressive aortic
dilation/dissection and mitral valve prolapse, repre-
sent the main cause of death. Patients who have un-
dergone surgical correction for mitral valve prolapse
and insufficiency may ultimately develop end-stage
congestive heart failure2,3 for which heart transplanta-
tion is the only life-saving procedure. Aortic dissec-
tion is uncommon in cardiac allograft recipients3 but
it is a potential complication in those with Marfan
syndrome.
Case Report
In 2003 a 36-years-old male with Marfan syndrome
was referred to our hospital for cardiac transplantation
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the patient has been underwent the Bentall operation
(mitral and tricuspid valve repair for ascending aortic
aneurysm, mitral and tricuspid valve regurgitation).
An MRI study performed in 2003, before heart trans-
plantation, did not show any morphologic or dimen-
sional anomaly of the arch (30 mm) or descending
thoracic aorta (29 mm). After heart transplantation
the patient underwent a standardized immuno-
suppression therapy protocol with cyclosporin A,
mychophenolato mofetil and prednisone, tapered as
dictated by clinical status. Thirty days after transplan-
tation the patient complained of a sudden, severe,
infrascapular back pain. MR angiography showed
Type-B aortic dissection (Fig. 1): the entry site was
below the origin of the left subclavian artery, the inti-
mal flap extended to the common iliac arteries and
there was a slight increase of the descending aortic
diameter (31 mm).
Since the patient’s clinical condition was stable,
with normal systemic pressure, he was discharged
and followed with CT scan or MRI every 6 months.
Initially the annual increase in aortic diameter was
limited to 3e4 mm but 2 years later MRI revealed
a sudden dimension increase, to 21 mm of the false lu-
men, with maximum diameter of true and false lumenrved.
359Unusual Rapid Evolution of Type B Aortic DissectionFig. 1. MR MIP (AeB) and MDCT MIP (CeD) images before (AeC) and after (D) EVT. Image of the aorta before (A) and
after (BeC) heart transplant and dissection: a substantial aortic luminal enlargement is seen during three years of follow-up
(AeC, from 2002 to 2005); intimal flap is shown (arrowhead). Endovascular stent graft placed in the descending thoracic
aorta (D) with complete thrombosis of the false lumen (arrow).of 55 mm in the proximal thoracic segment, 45 mm in
the thoracic aorta below the diaphragm and 36 mm in
the abdominal aortic segment. Because of the high
risk of open surgical repair, the patient underwent en-
dovascular stent-graft treatment. The procedure was
performed under general anaesthesia with surgical
exposure of common femoral artery. Three Valiant
thoracic stent grafts segments (Medtronic, Santa
Rosa, CA) were delivered under fluoroscopic and
TEE guidance under hypotension, the most proximal
stent with bare spring was placed below the left com-
mon carotid artery and the most distal with closed
web 2 cm above the coeliac artery. The diameter of
the stent-graft was oversized by 10% with respect
to the aortic arch diameter. Post-procedural angiogra-
phy and TEE showed closure of the primary and of
two additional thoracic entry sites, with false lumen
thrombosis down to the coeliac artery. The post-
operative course was uneventful, with the exception
of a pronounced post-implantation syndrome (fever,elevated C-reactive protein levels, and leukocytosis).
The patient was discharged on the 14th postoperative
day. CT scan performed during follow-up (one year)
showed a complete occlusion of the thoracic false
lumen down to the coeliac artery (Fig. 2) with initial
external sac shrinkage of 3 mm. The false lumen
remained open in the abdominal aortic segment but
without any further increase in sac diameter.
Discussion
Management of patients with Marfan syndrome still
constitutes a challenge and some are reluctant to place
these patients on heart transplantation waiting lists.3
A variety of aortic complications can occur. The con-
nection between the donor and the recipient aorta is
a potential source of early and late complications as
a result of infection, compliance mismatch and weak-
ness of the aortic wall. In patients with MarfanEur J Vasc Endovasc Surg Vol 32, October 2006
360 L. Botta et al.Fig. 2. TEE images of the endovascular procedure. A: type B dissection with small true lumen (TL) and large false (FL) lu-
men without any thrombus. The guide-wire (arrow) is inside the TL. B: colour Doppler image immediate after stent place-
ment: true lumen expansion, initial slow flow in the false lumen. A limited peri-graft leak is visible (arrow). C: colour
Doppler image at the end of the procedure. Disappearance of the peri-graft leak with slow flow and initial thrombosis
of the false lumen (arrow).syndrome, there is a 40% incidence of post-operative
thoracic aorta dissection, while dissection is extremely
rare outside this setting, varying from 1e2%.2 The
mechanism of post-operative aortic aneurysm and
dissection formation is probably multifactorial. It
has been suggested that, with improved cardiac out-
put and abrupt change in systemic pressure, the aorta
is exposed to increased stress by the transplanted heart.4
Another possible contributor is immunosuppression,
because of collagen-weakening effect, secondary hyper-
tension and accelerated atherosclerosis.
The expected increase of aortic diameter in
uncomplicated type-B dissections also with Marfan
syndrome is about 3 mm/year.5 Accordingly, an
annual increase of 10 mm in aortic diameter has
been reported in abdominal aortic aneurysm in heart
transplant recipients.6 An adjunct problem in these
patients is that beta-blockers therapy, useful to control
the rate of pressure change with time (dp/dt) in aortic
dissection, should be administered cautiously, since
circulating cathecolamines appear crucial for adequate
e cardiac function of the grafted heart during exercise.
The feasibility of endovascular repair in Marfan
syndrome is widely debated,7 because of the potential
risk induced by radial forces of the stent-graft upon
the fragile aortic wall. However, conventional surgery
for descending aorta dissection carries a high risk in
these patients. In our case, open surgery could be
aggravated by several adjunct problems, such asEur J Vasc Endovasc Surg Vol 32, October 2006discontinuation of immunosuppressive therapy, in-
creased risk of infection or alterations in the coagula-
tion system.
In conclusion, endovascular repair is a recognised
appropriate alternative to open surgery in high risk
patients and may represent the only life-saving ap-
proach when multiple co-morbidities are present.
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